Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Deficiency

v3.7.0.1
Stockholders' Deficiency
3 Months Ended
Mar. 31, 2017
Equity [Abstract]  
Stockholders' Deficiency

7.       STOCKHOLDERS’ DEFICIENCY

 

PREFERRED STOCK

 

SERIES A CONVERTIBLE PREFERRED STOCK

 

The Series A Convertible Preferred Stock shall have no liquidation preference so long as the Series C Convertible Preferred Stock shall be outstanding.

 

SERIES B CONVERTIBLE PREFERRED STOCK

 

On December 31, 2016, the Company received a notice of redemption from the creditors committee of the ECOtality estate to redeem 2,750 shares of Series B Convertible Preferred Stock for $275,000. As of March 31, 2017, the redemption amount remained outstanding. The Company has the option to settle the redemption request either by the repayment in cash or by the issuance of shares of common stock.

 

As of March 31, 2017, the liquidation preference for the Series B Convertible Preferred Stock amounted to $825,000.

 

SERIES C CONVERTIBLE PREFERRED STOCK

 

As of March 31, 2017, and December 31, 2016, the Company recorded a dividend payable liability on the shares of Series C Convertible Preferred Stock of $1,905,000 and $1,150,100, respectively. See Note 4 – Accrued Expenses. Subsequent to March 31, 2017, the Company issued Series C Convertible Preferred Stock in satisfaction of the liability. See Note 10 – Subsequent Events - Series C Convertible Preferred Stock for additional details.

 

In the event of a liquidation, the Series C Convertible Preferred Stock is also entitled to a liquidation preference equal to the stated value plus any accrued and unpaid dividends, which, as of March 31, 2017, was equal to $16,947,600.

 

NON-CONTROLLING INTERESTS

 

350 Green is not owned by the Company but is deemed to be a VIE where the entirety of its results of operations are consolidated in the Company’s financial statements.

 

STOCK-BASED COMPENSATION

 

The Company recognized stock-based compensation expense related to preferred stock, common stock, stock options and warrants for the three months ended March 31, 2017 and 2016 of $167,248 and $561,246, respectively, which is included within compensation expense on the condensed consolidated statement of operations. As of March 31, 2017, there was $30,947 of unrecognized stock-based compensation expense that will be recognized over the weighted average remaining vesting period of 0.25 years.